The prefrontal-limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain

Progress in Neurobiology

Volumn 93, Issue 4, 2011, Pages 468-487

  Bennett, M R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amygdala; Basal ganglia; Cingulate cortex; Depression; Hippocampus; Hypothalamus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DOPAMINE RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMATE RECEPTOR; SEROTONIN;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; BASAL GANGLION; CORPUS STRIATUM; EPIGENETICS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MAJOR DEPRESSION; MESENCEPHALON; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOSIS; RAPHE NUCLEUS; REVIEW; SUICIDAL IDEATION; SYNAPSE;

BASAL GANGLIA; DEPRESSION; EPIGENOMICS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; LIMBIC SYSTEM; MESENCEPHALON; NEURAL PATHWAYS; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, GLUTAMATE; RECEPTORS, SEROTONIN; RISK FACTORS; SUICIDE;

EID: 79952501748     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.01.006     Document Type: Review

References (223)

1. Abi-Dargham A., Gil R., Krystal J., Baldwin R., et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 1998, 155(6):761-767.
2. Abi-Dargham A., Rodenhiser J., Printz D., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(14):8104-8109.
3. Ahearn E.P., Jamison K.R., Steffens D.C., et al. MRI correlates of suicide attempt history in unipolar depression. Biol. Psychiatry 2001, 50(4):266-270.
4. Ahlenius S. Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs. Pharmacol. Toxicol. 1999, 84(5):193-19666.
5. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 2007, 113(2):296-320.
6. Alexander G.E., Crutcher M.D. Neural representations of the target (goal) of visually guided arm movements in three motor areas of the monkey. J. Neurophysiol. 1990, 64(1):164-178.
7. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbergsweig D., Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 1997, 54(10):915-922.
8. Alt S.R., Turner J.D., Klok M.D., et al. Differential expression of glutocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 2009, 35(4):544-556.
9. Autry A.E., Adachi M., Cheng P., Monteggia L.M. Gender-specific impact of brain-derived neurotrphic factor signaling on stress-induced depression-like behavior. Biol. Psychiatry 2009, 66(1):84-90.
10. Balleine B.W., Liljeholm M., Ostlund S.B. The integrative function of the basal ganglia in instrumental conditioning. Behav. Brain Res. 2009, 199(1):43-5258.
11. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35(1):48-69.
12. Ballmaier M., Toga A.W., Blanton R.E., et al. Anterior cingulated gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am. J. Psychiatry 2004, 161(1):99-108.
13. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38(8):1083-1152.
14. Bennett M.R. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust. N. Z. J. Psychiatry 2009, 43(8):711-721.
15. Bennett M.R. The prefrontal-limbic network in depression: a core pathology of synaptic regression. Prog. Neurobiol 2011, 93(4):457-467.
16. Bennett M.R. Depression and synapse regression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity. Aust. N. Z. J. Psychiatry 2010, 44(4):301-308.
17. Bennett M.R. Stress and anxiety in schizophrenia and depression: glucocorticoids, cortico-tropin releasing hormone and synapse regression. Aust. N. Z. J. Psychiatry 2008, 42:995-1002.
18. Bensley L.S., Van Eenwyk J., Spieker S.J., Schoder J. Self-reported abuse history and adolescent problem behaviors. 1. Antisocial and suicidal behaviors. J. Adolesc. Health 1999, 24(3):163-172.
19. Bonelli R.M., Kapfhammer H.P., Pillay S.S., Yurgelun-Todd D.A. Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?. J. Neural Transm. 2006, 113(2):255-268.
20. Borsini F., Ceci A., Bietti G., Donetti A. BIMT 17, a 5HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 352(3):283-290.
21. Bortolozzi A., Amargós-bosch M., Adell A., et al. In vivo modulation of 5-hydroxy-trytamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. Eur. J. Neurosci. 2003, 18(5):1235-1246.
22. Bortolozzi A., Diaz-Mataix L., Scorza M.C., Celada P., Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 2005, 95(6):1597-1607.
23. Boyle M.P., Brewer J.A., Funatsu M., et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(2):473-478.
24. Boyle M.P., Kolber B.J., Vogt S.K., Wozniak D.F., Muglia L.J. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J. Neurosci. 2006, 26(7):1971-1978.
25. Brambilla P., Nicoletti M.A., Harenski K., et al. Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology 2002, 27(5):792-799.
26. Bramham C.R. Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog. Brain Res. 2007, 163:453-471.
27. Bray P.J., Cotton R.G. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum. Mutat. 2003, 21(6):557-568.
28. Bremner J.D., Vythilingam M., Vermetten E., et al. Reduced volume of orbitofrontal cortex in major depression. Biol. Psychiatry 2002, 51(4):273-279.
29. Brent D.A., Bridge J., Johnson B.A., Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch. Gen. Psychiatry 1996, 53(12):1145-1152.
30. Brent D.A., Johnson B.A., Perper J., et al. Personality disorder, personality traits impulsive violence, and completed suicide in adolescents. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33(8):1080-1086.
31. Brezo J., Paris J., Barker E.D., et al. Natural history of suicidal behaviors in a population-based sample of young adults. Psychol. Med. 2007, 37(11):1563-1574.
32. Brody A.L., Barsom M.W., Bota R.G., Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin. Clin. Neuropsychiatry 2001, 6(2):102-112.
33. Brozoski T.J., Brown R.M., Rosvold H., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979, 205(4409):929-932.
34. Caetano S.C., Hatch J.P., Brambilla P., et al. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res. 2004, 132(2):141-147.
35. Carlsson A., Carlsson M.L. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin. Neurosci. 2006, 8(1):137-142.
36. Carlsson A., Waters N., Carlsson M.L. Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 24(Suppl. 4):37-43.
37. Carlsson A. Schizophrenia: a neurotransmitter imbalance syndrome?. Yakubutsu. Seishin. Kodo. 1990, 10(1):35-42.
38. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006, 39(Suppl. 1):S10-S14.
39. Carlsson M., Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?. Schizophr. Bull. 1990, 16:425-432.
40. Carvalho A.L., Caldeira M.V., Santos S.D., Duarte C.B. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br. J. Pharmacol. 2008, 153(Suppl. 1):S310-S324.
41. Castrén E., Vöikar V., Rantamäki T. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 2007, 7(1):18-21.
42. Champagne D.L., Bagot R.C., van Hasselt F., et al. Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning and differential responsiveness to glucocorticoids and stress. J. Neurosci. 2008, 28(23):6037-6045.
43. Coffey C.E., Figiel G.S., Djang W.T., Weiener R.D. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am. J. Psychiatry 1990, 147(2):187-189.
44. Compan V., Segu L., Buhot M.C., Daszuta A. Selective increases in serotonin. 5HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. Brain Res. 1998, 793(1/2):103-111.
45. Corbit L.H., Balliene B.W. The role of prelimbic cortex in instrumental conditioning. Behav. Brain Res. 2003, 146(1/2):145-157.
46. Daffner K.R., Mesulam M.M., Holcomb P.J., et al. Disruption of attention to novel events after frontal lobe injury in humans. J. Neurol. Neurosurg. Psychiatry 2000, 68(1):18-24.
47. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: review and reconceptualization. Am. J. Psychiatry 1991, 148(11):1474-1486.
48. Daw, O'Doherty J.P., Dayan P., Seymour B., Dolan R.J. Cortical substrates for exploratory decisions in humans. Nature 2006, 441(7095):876-879.
49. Day M.M., Wokosin D., Plotkin J.L., Tian X., Surmeier D.J. Differential excitability and modulation of striatal medium spiny neuron dendrites. J. Neurosci. 2008, 28(45):11604-11614.
50. De Bellis M.D., Chrousos G.P., Dorn L.D., et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J. Clin. Endocrinol. Metab. 1994, 78(2):249-255.
51. Dedovic K., Duchesne A., Andrews J., Engert V., Pruessner J.C. The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage 2009, 47(3):864-871.
52. Diaconu G., Turecki G. Family history of suicidal behavior predicts impulsive-aggressive behavior levels in psychiatric outpatients. J. Affect. Disord. 2009, 113(1/2):172-178.
53. Di Matteo V., Pierucci M., Esposito E., Crescimanno G., Benigno A., Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog. Brain Res. 2008, 172:423-463.
54. Diaz Heijtz R., Kolb B., Forssberg H. Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain?. Eur. J. Neurosci. 2003, 18(12):3394-3399.
55. Diaz-Mataix L., Artigas F., Celada P. Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist. Eur. Neuropsychopharmacol. 2006, 16(4):288-296.
56. Diaz-Mataix L., Scorza M.C., Bortolozzi A., Toth M., Celada P., Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J. Neurosci. 2005, 25(47):10831-10843.
57. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13(9):3839-3847.
58. Drevets W. Orbitofrontal cortex function and structure in depression. Ann. N. Y. Acad. Sci. 2007, 1121:499-527.
59. Drevets W., Price J., Simpson J., Todd R., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386(6627):824-827.
60. Dumais A., Lesage A.D., Alda M., et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 2005, 162(11):2116-2124.
61. Dutta R., Greene T., Addington J., McKenzie K., Phillips M., Murray M. Biological life course and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophr. Bull. 2007, 33(4):868-876.
62. Duvarci S., Paré D. Glucocorticoids enhance the excitability of principal basolateral amygdala neurons. J. Neurosci. 2007, 27(16):4482-4491.
63. Dwivedi Y., Rizav i.H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60(8):804-815.
64. Ehrlich S., Breeze J.L., Hesdorffer D.C., et al. White matter hyperintensities and their association with suicidality in depressed young adults. J. Affect. Disord. 2005, 86(2/3):281-287.
65. Ernst C., Deleva V., Deng X., et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 2009, 66(1):22-32.
66. Evans E., Hewton K., Rodham K. Suicide phenomena and abuse in adolescents: a review of epidemiological studies. Child Abuse Negl. 2005, 29:45-58.
67. Fergusson D.M., Horwood L.J., Lynskey M.T. Childhood sexual abuse and psychiatric disorder in young adulthood. II. Psychiatric outcomes of childhood sexual abuse. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35(10):1365-1374.
68. Fink J.K. Advances in hereditary spastic paraplegia. Curr. Opin. Neurol. 1997, 10(4):313-318.
69. Flores G., Wood G.K., Liang J.J., Quirion R., Srivastava L.K. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J. Neurosci. 1996, 16(22):7366-7375.
70. Freedman L.J., Insel T.R., Smith Y. Subcortical projections of area 25 (subgenual cortex) of the macaque monkey. J. Comp. Neurol. 2000, 421(2):172-188.
71. Fuchikami M., Morinobu S., Kurata A., Yamamoto S., Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int. J. Neuropsychopharmacol. 2009, 12(1):73-82.
72. Fuchs E., Flugge G., Czeh B. Remodeling of neuronal networks by stress. Front. Biosci. 2006, 11:2746-2758.
73. Garcia R. Stress, hippocampal plasticity and spatial learning. Synapse 2001, 40(3):180-183.
74. Gareri P., De Fazio P., De Sarro G. Neuropharmacology of depression in aging and age related diseases. Aging Res. Rev. 2002, 1(1):113-134.
75. Gerfen C.R., Engber T.M., Mahan I.C., et al. D1 and 2 dopamine receptor-regulated gene expression of striato nigral and striato pallidal neurons. Science 1990, 250(4986):1429-1432.
76. Glowinski A.L., Bucholz K.K., Nelson E.C., et al. Suicide attempts in an adolescent female twin sample. J. Am. Acad. Child Adolesc. Psychiatry 2001, 40(11):1300-1307.
77. Goldapple K., Segal Z., Garson C., et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 2004, 61(1):34-41.
78. Goodwin G.M. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J. Psychopharmacol. 1997, 11(2):115-122.
79. Goto Y., Grace A.A. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci. 2008, 31(11):552-558.
80. Gräff J., Mansuy I.M. Epigenetic codes in cognition and behaviour. Behav. Brain Res. 2008, 192(1):70-87.
81. Grahn J.A., Parkinson J.A., Owen A.M. The cognitive functions of the caudate nucleus. Prog. Neurobiol. 2008, 86(3):141-155.
82. Gray J.A., Roth B.L. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 2007, 33(5):1100-1119.
83. Graybiel A.M. Habits, rituals and the evaluative brain. Annu. Rev. Neurosci. 2008, 31(359):387.
84. Greenwald B.S., Kramer-Ginsberg E., Krishnan R.R., Ashtar I.M., Aupperle P.M., Patel M. MRI signal hyperintensities in geriatric depression. Am. J. Psychiatry 1996, 153(9):1212-1215.
85. Gurevich E.V., Joyce J.N. Alterations in the cortical seretonergic system in schizophrenia: a postmortem study. Biol. Psychiatry 1997, 42(7):529-545.
86. Haber S.N., Fudge J.L., McFarland N.R. Striatonegro striatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 2000, 20(6):2369-2382.
87. Haber S.N., Kim K.S., Mailly P., Calvazara R. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections. providing a substrate for incentive-based learning. J. Neurosci. 2006, 26(3):8368-8376.
88. Haber S.N., Kunishio K., Mizobuchi M., Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J. Neurosci. 1995, 15(7 Pt 1):4851-4867.
89. Haber S.N. The primate basal ganglia: parallel and integral networks. J. Chem. Neuroanat. 2003, 26(4):317-330.
90. Häfner H., van der Heiden W., Maurer K. Evidence for separate diseases? Stages of one disease or different combinations of symptom dimensions?. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258(Suppl. 2):85-96.
91. Hampton A., Bossaerts P., O'Doherty J.P. The role of the ventromedial prefrontal cortex in abstract state-based inference during decision making in humans. J. Neurosci. 2006, 26:8360-8367.
92. Heim C., Newport D.J., Heit S., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284(5):592-597.
93. Helmeke C., Seidel K., Poeggel G., Bredy T.W., Abraham A., Braun K. Paternal deprivation during infancy results in dendrite- and time-specific changes of dendritic development and spine formation in the orbitofrontal cortex of the biparental rodent Octodon degus. Neuroscience 2009, 163(3):790-798.
94. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic systems mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(8):1201-1213.
95. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M.P., Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol. Psychiatry 1995, 37(3):151-160.
96. Hickie I.B., Naismith S.L., Ward P.B., et al. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J. Affect. Disord. 2007, 98(1/2):137-142.
97. Holsboer F. The stress hormone system is back on the map. Curr. Psychiatry Rep. 2000, 2(6):454-456.
98. Hoptman M.J., Gunning-Dixon F.M., Murphy C.F., Lim K.O., Alexopoulos G.S. Structural neuroimaging research methods in geriatric depression. Am. J. Geriatr. Psychiatry 2006, 14(10):812-822.
99. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Grasby P.M., McGuire P.K. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br. J. Psychiatry Suppl. 2007, 51:s13-s18.
100. Huttunen J., Heinimaa M., Svirskis T., et al. Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol. Psychiatry 2008, 63:114-117.
101. Ichikawa J., Ishii H., Bonaccorso S., Fowler W.L., O'Laughglan I.A., Meltzer H.Y. 5-HTT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation; a possible mechanism of atypical antipsychotic-induced cortical dopamione release. J. Neurochem. 2001, 76(5):1521-1531.
102. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33(Suppl.):245-254.
103. Jiao H., Zhang L., Gao F., Lou D., Zhang J., Xu M. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced signaling via NMDA receptor phosphorylation. J. Neurochem. 2007, 103(2):840-848.
104. Joëls M., de Kloet E.R. Effect of corticosteroid hormones on electrical activity in rat hippocampus. J. Steroid Biochem. Mol. Biol. 1991, 40(1-3):83-86.
105. Jokinen J., Nordström P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J. Affect. Disord. 2009, 116(1/2):1170-2120.
106. Jueptner M., Frith C.D., Brooks D.J., Frackowiak R.S., Passingham R.E. Anatomy of motor learning. II. Subcortical structures and learning by trial and error. J. Neurophysiol. 1997, 77(3):1325-1337.
107. Kanner K.R. Neuroanatomic substrates of depression in the elderly. J. Geriatr. Psychiatry Neurol. 1993, 243(1):41-46.
108. Kapur S., Remington G. Serotonon-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 1996, 153(4):466-476.
109. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109(2):143-148.
110. Karst H., Nair S., Velzing E., Rumpff-van Essen L., Slagter E., et al. Glucocorticoids alter calcium conductances and calcium channel subunit expression in basolateral amygdala neurons. Eur. J. Neurosci. 2002, 16(6):1083-1089.
111. Kaur S., Sassi R.B., Axelson D., et al. Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am. J. Psychiatry 2005, 162(9):1637-1643.
112. Kellendonk C., Simpson E.H., Polan H.J., et al. Transient and selective over-expression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006, 49(4):603-615.
113. Kern S., Oakes T.R., Stone C.K., McAuliff E.M., KIrschbaum C., Davidson R.J. Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor. Psychoneuroendocrinology 2008, 33(4):517-529.
114. Kim C.D., Seguin M., Therrien N., et al. Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am. J. Psychiatry 2005, 162(5):1017-1019.
115. Kim H., Shimojo S., O'Doherty J.P. Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS Biol. 2006, 4(8):233.
116. Kim J.J., Haller J. Glucocorticoid hyper- and hypofunction: stress effects on cognition and aggression. Ann. N. Y. Acad. Sci. 2007, 1113:291-303.
117. Kolber B.J., Wieczorek L., Muglia L.J. Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress 2008, 11(5):321-338.
118. Kopell B.H., Greenberg B.D. Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci. Biobehav. Rev. 2008, 32(3):408-422.
119. Korz V., Frey J.U. Stress-related modulation of hippocampal long-term potentiation in rats: involvement of adrenal steroid receptors. J. Neurosci. 2003, 23(19):7281-7287.
120. Kretz O., Reichardt H.M., Schütz G., Bock R. Corticotropin-releasing hormone expression in the major target for glucocorticoid feedback-control at the hypothalamic level. Brain Res. 1999, 818(2):488-491.
121. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 2004, 72(5):341-372.
122. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. Am. J. Psychiatry 1997, 154(4):497-591.
123. Krishnan K.R., McDonald W.M., Doraiswamy P.M., et al. Neuroanatomical substrates of depression in the elderly. Eur. Arch. Psychiatry Clin. Neurosci. 1993, 243(1):41-46.
124. Krishnan K.R. Neuroanatomic substrates of depression in the elderly. J. Geriatr. Psychiatry 1993, 6(1):39-58.
125. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455(7215):894-902.
126. Kumar A., Bilker W., Jin Z., Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 2000, 22(3):264-274.
127. Kuroki T., Meltzer H.Y., Ichikawa J. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumben. J. Pharmacol. Exp. Ther. 1999, 288(2):774-781.
128. Lacerda A.L., Keshavan M.S., Hardan A.Y., et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol. Psychiatry 2004, 55(4):353-358.
129. Lafer B., Renshaw P.F., Sachs G.S. Major depression and the basal ganglia. Psychiatr. Clin. North Am. 1997, 20(4):885-896.
130. Laruelle M., Kegeles L.S., Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathphysiology to treatment. Ann. N. Y. Acad. Sci. 2003, 1003:138-158.
131. Lawrence A.D., Sales T., Quested D., Grasby P. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Arch. Gen. Psychiatry 2004, 61(2):134-142.
132. Lee S.H., Payne M.E., Steffens D.C., et al. Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biol. Psychiatry 2003, 54(5):529-533.
133. Lehéricy S., Benali H., Van de Moortele, et al. Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12566-12571.
134. Lesser I.M., Boone K.B., Mehringer C.M., Wohl M.A., Miller B.L., Berman N.G. Cognition and white matter hyperintensities in older depressed patients. Am. J. Psychiatry 1966, 153(10):1280-1287.
135. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second generation versus first-generation antipsychotic drugs for schizophhenia: a meta-analysis. Lancet 2009, 373(9857):31-41.
136. Lévesque J., Eugène F., Joanette Y., et al. Neural circuitry underlying voluntary suppression of sadness. Biol. Psychiatry 2003, 53(6):502-510.
137. Li Z., Ichikawa J., Dai J., Meltzer H.Y. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur. J. Pharmacol. 2004, 493(1-3):75-83.
138. Liu D., Diorio J., Tannenbaum B., et al. Maternal care, hippocampal glucocorticoid receptors and hypothalamic-pituitary-adrenal responses to stress. Science 1997, 277(5332):1659-1662.
139. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995, 5(2):205-216.
140. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism. 2005, 54(5 Suppl. 1):20-23.
141. McGirr A., Paris J., Lesage A., Renaud J., Turecki G. Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression. J. Clin. Psychiatry 2007, 68(5):721-729.
142. McGirr A., Séguin M., Renaud J., Benkelfat C., Alda M., Turecki G. Gender and risk factors for suicide: evidence for heterogeneity in predisposing mechanisms in a psychological autopsy study. J. Clin. Psychiatry 2006, 67(10):1612-1617.
143. McGowan P.O., Sasaki A., D'Alessio A.C., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12(3):342-348.
144. McGowan P.O., Sasaki A., Huang T.C., et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One 2008, 3(5):e2085.
145. Meaney M.J., Szyf M., Secki J.R. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol. Med. 2007, 13(7):269-277.
146. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 2001, 24:1161-1192.
147. Mijnster M.J., Raimundo A.G., Koskub K., et al. Regional and cellular distribution of serotonin 5-hydroxytryptamine 2a receptor mRNA in the nucleus accumbens, olfactory tubercle and putamen of the rat. J. Comp. Neurol. 1997, 389(1):1-11.
148. Missale C., Fiorentu C., Busi C., Collo G., Spano P.F. NMDA/D1 receptor complex as a new target in drug development. Curr. Top. Med. Chem. 2006, 6(8):801-808.
149. Mitra R., Ferguson D., Sapolsky R.M. Mineralocorticoid receptor overexpression in baso-lateral amygdala reduces corticosterone secretion and anxiety. Biol. Psychiatry 2009, 66(7):686-690.
150. Monkul E.S., Hatch J.P., Nicoletti M.A., et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol. Psychiatry 2007, 12(4):360-366.
151. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 1993, 157(1):53-56.
152. Naismith S., Hickie I., Ward P.B., et al. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am. J. Psychiatry 2002, 159(12):2096-2098.
153. Nebes R.D., Reynolds C.F.3rd., Boada F., et al. Longitudinal increase in the volume of white matter hyperintensities in late-onset depression. Int. J. Geriatr. Psychiatry 2002, 17(6):526-530.
154. Neve K.A., Seamans J.K., Tranttham-Davidson H. Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 2004, 24:165-205.
155. Oberlander T.F., Weinberg J., Papsdorf M., Grunau R., Misri S., Devlin A.M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress response. Epigenetics 2008, 3(2):97-106.
156. Ongür D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(22):13290-13295.
157. Ongür D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 2000, 10(3):206-219.
158. Pavlides C., Watanabe Y., McEwen B.S. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993, 3(2):183-192.
159. Pawlak V., Kerr J.N. Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity. J. Neurosci. 2008, 28(10):2435-2446.
160. Peralta V., Cuesta M.J. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr. Res. 2001, 49(3):269-285.
161. Pompili M., Ehrlich S., De Pisa E., et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257(8):494-499.
162. Pompili M., Innamorati M., Mann J.J., et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(6):1501-1507.
163. Puig M.V., Artigas F., Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. Cereb. Cortex 2005, 15(1):1-14.
164. Reichardt H.M., Kaestner K.H., Wessely O., Gass P., Schmid W., Schütz G. Analysis of glucocorticoid signalling by gene targeting. J. Steroid Biochem. Mol. Biol. 1998, 65(1-6):111-115.
165. Reichardt H.M., Tronche F., Bauer A., Schütz G. Molecular genetic analysis of glucocorticoid signaling using the Cre/loxP system. Biol. Chem. 2000, 381(9/10):961-964.
166. Ridder S., Hourbaji S., Hellweg R., et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 2005, 25(26):6243-6250.
167. Robinson R.G., Chemerinski E., Jorge R. Pathophysiology of secondary depressions in the elderly. J. Geriatr. Psychiatry Neurol. 1999, 12(3):128-136.
168. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 1999, 11(5):1598-1604.
169. Rogers M.A., Bradshaw J.L., Pantellis C., Phillips J.G. Frontostriatal deficits in unipolar major depression. Brain Res. Bull. 1998, 47(4):297-310.
170. Rollema H., Lu Y., Schmidt A.W., Sprouse J.S., Zorn S.H. 5-HT(1A) receptor activation contributes to ziiprasidoe-induced dopamine release in the rat prefrontal cortex. Biol. Psychiatry 2000, 48(3):229-237.
171. Rollema H., Lu Y., Schmidt A.W., Zorn S.H. Clozapine increases dopamine release in prefrontal cortex by HT1A receptor activation. Eur. J. Pharmacol. 1997, 338(2):R3-R5.
172. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 2009, 65(9):760-769.
173. Roy A., Segal N.L., Centerwall B.S., Robinette C.D. Suicide in twins. Arch. Gen. Psychiatry 1991, 48(1):29-32.
174. Roy A., Segal N.L., Sarchiapone M. Attempted suicide among living co-twins of twin suicide victims. Am. J. Psychiatry 1995, 152(7):1075-1076.
175. Saint-Cyr J.A., Taylor A.E., Nicholson K. Behavior and the basal ganglia. Behav. Neurol. Mov. Disord. 1995, 65:1-28.
176. Salloway S., Malloy P., Kohn R., et al. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996, 46(6):1567-1574.
177. Schulsinger S., Kety D., Rosenthal, et al. A family study of suicide. Origins, Prevention and Treatment of Affective Disorders. 1979, 277-287. Academic Press Inc., New York, N.Y. M. Schou, E. Stromgren (Eds.).
178. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 2004, 74(1):1-58.
179. Segal M., Greenberger V., Korkotian E. Formation of dendritic spines in cultured striatal neurons depend on excitatory afferent activity. Eur. J. Neurosci. 2003, 17:2573-2585.
180. Séguin M., Lesage A., Turecki G., et al. Life trajectories and burden of adversity: mapping the developmental profiles of suicide mortality. Psychol. Med. 2007, 37(11):1575-1583.
181. Sesak S.R., Carr D.B., Omelchenko N., Pinto A. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann. N. Y. Acad. Sci. 2003, 1003:36-52.
182. Shah P.J., Glabus M.F., Goodwin G.M., Ebmeier K.P. Chronic, treatment-resistant depression and right fronto-striatal atrophy. Br. J. Psychiatry 2002, 180:434-440.
183. Shen H., Sesack S.R., Toda S., Kalivas P.W. Automated quantification of dendritic spine density and spine head diameter in medium spiny neurons of the nucleus accumbens. Brain Struct. Funct. 2008, 213(1/2):149-157.
184. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 1997, 31(4):393-432.
185. Spokas M., Wenzel A., Stirman S.W., Brown G.K., Beck A.T. Suicide risk factors and mediators between childhood sexual abuse and suicide ideation among male and female attempters. J. Trauma. Stress 2009, 22(5):467-470.
186. Stahl S.M. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr. 2007, 12(4):265-268.
187. Stahl S.M. Novel therapeutics for depression: l-methylfolate as a trimonoamine modulator and anti depressant-augmenting agent. CNS Spectr. 2007, 12739-12744.
188. Statham D.J., Heath A.C., Madden P.A., et al. Suicidal behaviour: an epidemiological and genetic study. Psychol. Med. 1998, 28(4):839-855.
189. Steffens D.C., Helms M.J., Krishnan K.R., Burke G.L. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999, 30(10):2159-2166.
190. Stephan K.E., Friston K.J., Frith C.D. Dysconnection in schizophrenia from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull. 2009, 35(3):509-527.
191. Stratowski S.M., Adler C.M., Del Bello M.P. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?. Bipolar Disord. 2002, 4(2):80-88.
192. Szyf M., Weaver I., Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod. Toxicol. 2007, 24(1):9-19.
193. Tanaka S.C., Doya K., Okada G., Ueda K., Okamoto Y., Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat. Neurosci. 2004, 7(8):887-893.
194. Tanaka T., Naquet R. Influence of subcortical stimulation on amygdaloid kindled cats. Appl. Neurophysiol. 1976, 39(3/4):302-305.
195. Tata D.A., Anderson B.J. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models. Implications for hippocampal volume reductions in depression. Physiol. Behav. 2010, 99(2):186-193.
196. Tata D.A., Marciano V.A., Anderson B.J. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J. Comp. Neurol. 2006, 498(3):363-374.
197. Taylor S.F., Liberzon L. Neural correlates of emotion regulation in psychopathology. Trends Cogn. Sci. 2007, 11(10):413-418.
198. Thomas A.J., Perry R., Barber R., Kalaria R.N., O'Brien J.T. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann. N. Y. Acad. Sci. 2002, 997:333-339.
199. Treadway M.T., Grant M.M., Ding Z., Hollon S.D., Gore J.C., Shelton R.C. Early adverse events. HPA activity and rostral anterior cingulate volume in MDD. PLoS One 2009, 4(3):e4887.
200. Tronche F., Kellendonk C., Kretz O., et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 1999, 23(1):99-103.
201. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9(4):519-525.
202. Tseng K.Y., O'Donnee P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J. Neurosci. 2004, 24(22):5131-5139.
203. Tupler L.A., Krishnan K.R., McDonald W.M., Dombeck C.B., D'Souza S., Steffens D.C. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. J. Psychosom. Res. 2002, 53(2):665-676.
204. Turner J.D., Muller C.P. Structure of the glucocorticoid receptor (NR3C1) gene 5′ untranslated region: identification, and tissue distribution of multiple new human exon 1. J. Mol. Endocrinol. 2005, 35(2):283-292.
205. Turner J.D., Schote A.B., Macedo J.A., Pelascini L.P., Muller C.P. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?. Biochem. Pharmacol. 2006, 72(11):1529-1537.
206. Valentin V.V., Dickinson A., O'Doherty J.P. Determining the neural substrates of goal-directed learning in the human brain. J. Neurosci. 2007, 27(15):4019-4026.
207. van Elst L.T., Woermann F.G., Lemieux L., Thompson P.J., Trimble M.R. Affective aggression in patients with temporal lobe epilepsy; a quantitative MRI study of the amygdala. Brain 2000, 123(Pt 2):234-243.
208. van Os J., Linscott R.J.J., Myin-Germeys I., Delespaul, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39(2):179-195.
209. Vythilingam M., Heim C., Newport J., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am. J. Psychiatry 2002, 159(12):2072-2080.
210. Weaver I.C., Cervoni N., Champagne F.A., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7(8):847-854.
211. Weaver I.C. Epigenetic effects of glucocorticoids. Semin. Fetal Neonatal Med. 2009, 14(3):143-150.
212. Wender P.H., Seymour S.K., Rosenthal D., Schulsinger F., Ortmann J., Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch. Gen. Psychiatry 1986, 43(10):923-929.
213. Widom C.S., DuMont K., Czaja S.J. A prospective investigation of major depressive disorder and comorbidity in abused and neglected children growing up. Arch. Gen. Psychiatry 2007, 64(1):49-56.
214. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995, 376(6541):572-657.
215. Yamada K., McEwen B.S., Pavlides C. Site and time dependent effects of acute stress on hippocampal long-term potentiation in freely behaving rats. Exp. Brain Res. 2003, 152(1):52-59.
216. Yasuto F., Suhara T., Ichimiya T., Takano A., Ando T., Okubo Y. Decreased 5-HT11A receptor binding in amygdala in schizophrenia. Biol. Psychiatry 2004, 55:439-444.
217. Yin H.H., Ostlund S.B., Knowlton B.J., Balleine B.W. The role of the dorsomedial striatum in instrumental conditioning. Eur. J. Neurosci. 2005, 22(2):513-523.
218. Yin H.H., Knowlton B.J., Balleine B.W. Blockade of NMDA receptors in the dorsomedial striatum prevents action-outcome learning in instrumental conditioning. Eur. J. Neurosci. 2005, 22(2):505-512.
219. Yin H.H., Knowlton B.J., Balleine B.W. Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning. Behav. Brain Res. 2006, 166(2):189-196.
220. Yuen E.Y., Jiang Q., Chen P., Gu Z., Feng J., Yan Z. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J. Neurosci. 2005, 25(23):5488-5501.
221. Zhong P., Yuen E.Y., Yan Z. Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex. Mol. Cell Neurosci. 2008, 38(2):290-299.
222. Zhu M.Y., Wang W.P., Huang J., Regunathan S. Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels. J. Neurochem. 2007, 103(Suppl. 1):1811-1820.
223. Zou B., Golarai G., Connor J.A., Tang A.C. Neonatal exposure to a novel environment enhances the effects of corticosterone on neural excitability and plasticity in adult hippocampus. Brain Res. Dev. Brain Res. 2001, 130(1):1-7.